RxNorm Semantic Concepts Index - 324
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "324".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 324 | IMP-aspartate ligase | Designated preferred name (PT) | NO | |
| RxCUI: 324 | IMP-aspartate ligase | Full form of descriptor (FN) | NO | |
| RxCUI: 324 | IMP-aspartate ligase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 324003 | bismuth dipropylacetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 324004 | butriptyline hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 324005 | D-transallethrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 324007 | dicresulene polymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 324009 | sargramostim 0.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 324012 | estradiol 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 324014 | boron citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 324026 | Allegra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 324028 | petroleum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 324031 | Carica papaya preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 324032 | Polaramine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 324033 | Celestone phosphate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 324034 | Epinal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 324036 | Podophyllum peltatum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 324039 | Frangula preparation | Designated preferred name (PT) | NO | |
| RxCUI: 324039 | Frangula preparation | Full form of descriptor (FN) | NO | |
| RxCUI: 324039 | Frangula preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 324039 | Frangula preparation | Designated preferred name (PT) | NO | |
| RxCUI: 324039 | Frangula preparation | Full form of descriptor (FN) | NO | |
| RxCUI: 324040 | Podophyllum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 324042 | Product containing hydrochlorothiazide and spironolactone (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 324042 | Product containing hydrochlorothiazide and spironolactone (medicinal product) | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 324042 | Product containing hydrochlorothiazide and spironolactone (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 324042 | Product containing hydrochlorothiazide and spironolactone (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 324044 | Desogestrel- and ethinylestradiol-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 324044 | Desogestrel- and ethinylestradiol-containing product | Designated preferred name (PT) | YES | |
| RxCUI: 324044 | Desogestrel- and ethinylestradiol-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 324044 | Desogestrel- and ethinylestradiol-containing product | Full form of descriptor (FN) | YES | |
| RxCUI: 324045 | Pyrabital | Designated preferred name (PT) | NO | |
| RxCUI: 324045 | Pyrabital | Full form of descriptor (FN) | NO | |
| RxCUI: 324049 | Aerosol | Dose Form Entry Term (ET) | Entry terms for dose forms (TTY=DF). | NO |
| RxCUI: 324051 | methylenedioxycinnamic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 324069 | Hypocretin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 324069 | Hypocretin | Designated preferred name (PT) | NO | |
| RxCUI: 324069 | Hypocretin | Full form of descriptor (FN) | NO | |
| RxCUI: 324072 | Dimeticone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 324072 | Dimeticone | Designated preferred name (PT) | YES | |
| RxCUI: 324072 | Dimeticone | Designated preferred name (PT) | YES | |
| RxCUI: 324072 | Dimeticone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 324072 | Dimeticone | Full form of descriptor (FN) | YES | |
| RxCUI: 324072 | Dimeticone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 324072 | Dimeticone | Full form of descriptor (FN) | YES | |
| RxCUI: 32411 | omoconazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 32411 | omoconazole | Designated preferred name (PT) | NO | |
| RxCUI: 32411 | omoconazole | Full form of descriptor (FN) | NO | |
| RxCUI: 32416 | Oncofoetal antigen | Designated preferred name (PT) | NO | |
| RxCUI: 32416 | Oncofoetal antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 32416 | Oncofoetal antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32437 | Oncogene protein sis | Designated preferred name (PT) | NO | |
| RxCUI: 32437 | Oncogene protein sis | Full form of descriptor (FN) | NO | |
| RxCUI: 32463 | Product containing rebamipide (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 32463 | Product containing rebamipide (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 32463 | Product containing rebamipide (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 32463 | Product containing rebamipide (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 3247 | Desipramine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 3247 | Desipramine | Designated preferred name (PT) | YES | |
| RxCUI: 3247 | Desipramine | Full form of descriptor (FN) | YES | |
| RxCUI: 3247 | Desipramine | Designated preferred name (PT) | YES | |
| RxCUI: 3247 | Desipramine | Full form of descriptor (FN) | YES | |
| RxCUI: 3248 | Desacetyllanatoside C | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3248 | Desacetyllanatoside C | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3248 | Desacetyllanatoside C | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 3248 | Desacetyllanatoside C | Designated preferred name (PT) | NO | |
| RxCUI: 3248 | Desacetyllanatoside C | Full form of descriptor (FN) | NO | |
| RxCUI: 3248 | Desacetyllanatoside C | Designated preferred name (PT) | NO | |
| RxCUI: 3248 | Desacetyllanatoside C | Full form of descriptor (FN) | NO | |
| RxCUI: 32485 | Orabase | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 3249 | Desmin | Designated preferred name (PT) | NO | |
| RxCUI: 3249 | Desmin | Full form of descriptor (FN) | NO | |
| RxCUI: 32496 | Orcinol hydroxylase | Designated preferred name (PT) | NO | |
| RxCUI: 32496 | Orcinol hydroxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 32496 | Orcinol hydroxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |